RGNX - REGENXBIO Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

RGNX is currently covered by 7 analysts with average potential upside of $20.15 (62.45%) backed by 50 price targets and 75 ratings. Documented since 20-Oct-2015. Analyst's average stock valuation to be materialised ratio is 30.86% with an average time for price targets to be met of 80.77 days.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 06-Mar-2023.

Highest price target for RGNX is 46, Lowest price target is 19, average price target is 32.5.

Currently, out of the existing stock ratings of RGNX - 14 which are a Hold (48.28%), 15 which are a Buy (51.72%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

46

$26.64 (137.60%)

50

22 days ago

2/18 (11.11%)

$18.11 (53.07%)

37

Buy

61

$41.64 (215.08%)

26 days ago

0/1 (0%)

$37.46 (159.13%)

Hold

14

$-5.36 (-27.69%)

14

2 months 5 days ago

12/15 (80%)

$-2.25 (-4.92%)

40

Buy

61

$39.29 (180.98%)

4 months 24 days ago

0/1 (0%)

$40.27 (194.26%)

Hold

29

$9.64 (49.79%)

55

5 months 24 days ago

1/7 (14.29%)

$11.11 (31.31%)

8

Show more analysts

What is RGNX(REGENXBIO Inc) average time for price targets to be met?

On average it took 80.77 days on average for the stock forecasts to be realized with a an average price target met ratio 30.86

Which analyst has the current highest performing score on RGNX(REGENXBIO Inc) with a proven track record?

GBOLA AMUSA